Two more biotechs leverage upsized offerings in IPO boom as Harbour pitches a raise in Hong Kong

The IPO market is still booming. Two more biotechs jumped onto Nasdaq this week with upsized offers, and a third has indicated that it wants a slice of the action.

Pennsylvania-based Harmony Biosciences Holdings $HRMY raised $128 million by offering 5.3 million shares at $24 apiece, exceeding the proposed range of $20 to $23 a share. On Wednesday, it closed at just over $37 per share.